Clinical trials
Phase 2 Musculoskeletal Diseases trials in Canada
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
12 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2011 | 1 |
| 2019 | 1 |
| 2020 | 2 |
| 2021 | 1 |
| 2022 | 1 |
| 2023 | 1 |
| 2024 | 1 |
| 2025 | 3 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Terminated | 4 |
| Enrolling by invitation | 3 |
| Completed | 2 |
| Recruiting | 2 |
| Active, not recruiting | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| QED Therapeutics, a BridgeBio company | 4 |
| Fulcrum Therapeutics | 2 |
| Bausch Health Americas, Inc. | 1 |
| BioMarin Pharmaceutical | 1 |
| Eli Lilly and Company | 1 |
| GlaxoSmithKline | 1 |
| PepGen Inc | 1 |
| Vertex Pharmaceuticals Incorporated | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Musculoskeletal Diseases | 12 |
| Bone Diseases | 5 |
| Genetic Diseases, Inborn | 5 |
| Dwarfism | 4 |
| Mucopolysaccharidosis IV | 4 |
| Neuromuscular Diseases | 4 |
| Osteochondrodysplasias | 4 |
| Achondroplasia | 3 |
| Muscular Dystrophies | 3 |
| Heredodegenerative Disorders, Nervous System | 2 |
Trials
Showing 1 to 12 of 12. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.